SUNREST — Sunrest Lifescience Income Statement
0.000.00%
Last trade - 00:00- IN₹229.58m
- IN₹281.02m
- IN₹294.83m
- 13
- 43
- 45
- 22
Annual income statement for Sunrest Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 169 | 269 | 246 | 295 |
| Cost of Revenue | ||||
| Gross Profit | 56 | 94.3 | 97.6 | 95 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 167 | 258 | 219 | 287 |
| Operating Profit | 2.31 | 10.4 | 27.7 | 8.1 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 2.24 | 10.5 | 27.4 | 5.93 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 1.65 | 7.77 | 20.4 | 2.26 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 1.65 | 7.77 | 20.4 | 2.26 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 1.66 | 7.77 | 20.4 | 2.26 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 0.386 | 1.77 | 4.76 | 0.68 |
| Dividends per Share |